HK92793A - Selenophen derivatives - Google Patents

Selenophen derivatives

Info

Publication number
HK92793A
HK92793A HK927/93A HK92793A HK92793A HK 92793 A HK92793 A HK 92793A HK 927/93 A HK927/93 A HK 927/93A HK 92793 A HK92793 A HK 92793A HK 92793 A HK92793 A HK 92793A
Authority
HK
Hong Kong
Prior art keywords
selenophen
derivatives
selenophen derivatives
Prior art date
Application number
HK927/93A
Other languages
English (en)
Inventor
Pierre Braquet
Colette Broquet
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of HK92793A publication Critical patent/HK92793A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D345/00—Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D421/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms
    • C07D421/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms containing two hetero rings
    • C07D421/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK927/93A 1989-11-22 1993-09-09 Selenophen derivatives HK92793A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898926392A GB8926392D0 (en) 1989-11-22 1989-11-22 Selenophen derivatives

Publications (1)

Publication Number Publication Date
HK92793A true HK92793A (en) 1993-09-17

Family

ID=10666721

Family Applications (1)

Application Number Title Priority Date Filing Date
HK927/93A HK92793A (en) 1989-11-22 1993-09-09 Selenophen derivatives

Country Status (31)

Country Link
US (1) US5075322A (fr)
JP (1) JP2686364B2 (fr)
KR (1) KR910009689A (fr)
AT (1) AT398570B (fr)
AU (1) AU624309B2 (fr)
BE (1) BE1004607A3 (fr)
CA (1) CA2029776C (fr)
CH (1) CH681079A5 (fr)
DE (1) DE4037187A1 (fr)
DK (1) DK276690A (fr)
DZ (1) DZ1460A1 (fr)
ES (1) ES2027507A6 (fr)
FI (1) FI89599C (fr)
FR (2) FR2654730B1 (fr)
GB (2) GB8926392D0 (fr)
GR (1) GR1000883B (fr)
HK (1) HK92793A (fr)
IE (1) IE64402B1 (fr)
IN (1) IN175709B (fr)
IT (1) IT1243921B (fr)
LU (1) LU87847A1 (fr)
MA (1) MA22001A1 (fr)
MY (1) MY104529A (fr)
NL (1) NL9002433A (fr)
NO (1) NO177568C (fr)
NZ (1) NZ235971A (fr)
OA (1) OA09330A (fr)
PT (1) PT95943B (fr)
SE (1) SE505908C2 (fr)
TN (1) TNSN90138A1 (fr)
ZA (1) ZA909026B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ330198A (en) * 1996-01-26 2000-06-23 Nattermann A & Cie Asthma therapeutic agents especially 2-phenyl-1,2-benzoisoselenazole-3(2H)-one
EP2619200A4 (fr) * 2010-09-22 2014-10-15 Calcimedica Inc Composés qui modulent le calcium intracellulaire

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH531000A (de) * 1970-03-11 1972-11-30 Sandoz Ag Verfahren zur Herstellung neuer Benzocycloheptathiophene

Also Published As

Publication number Publication date
GR900100781A (en) 1992-04-17
GB8926392D0 (en) 1990-01-10
NO177568B (no) 1995-07-03
FR2654622A1 (fr) 1991-05-24
GB9024589D0 (en) 1991-01-02
DZ1460A1 (fr) 2004-09-13
IT9022115A1 (it) 1992-05-20
FI905717A0 (fi) 1990-11-20
GB2238310A (en) 1991-05-29
NL9002433A (nl) 1991-06-17
SE9003704D0 (sv) 1990-11-21
KR910009689A (ko) 1991-06-28
FI89599C (fi) 1993-10-25
OA09330A (fr) 1992-09-15
DK276690D0 (da) 1990-11-21
BE1004607A3 (fr) 1992-12-22
JPH03170479A (ja) 1991-07-24
IN175709B (fr) 1995-08-19
FR2654730B1 (fr) 1995-01-13
FR2654730A1 (fr) 1991-05-24
GR1000883B (el) 1993-03-16
FI905717A (fi) 1991-05-23
AU624309B2 (en) 1992-06-04
AT398570B (de) 1994-12-27
IT1243921B (it) 1994-06-28
PT95943A (pt) 1991-09-13
TNSN90138A1 (fr) 1991-03-05
CA2029776C (fr) 1997-04-22
JP2686364B2 (ja) 1997-12-08
AU6678190A (en) 1991-06-06
LU87847A1 (fr) 1991-05-07
DK276690A (da) 1991-05-23
NO905047D0 (no) 1990-11-21
US5075322A (en) 1991-12-24
MY104529A (en) 1994-04-30
ES2027507A6 (es) 1992-06-01
GB2238310B (en) 1993-04-21
DE4037187A1 (de) 1991-05-23
PT95943B (pt) 1998-01-30
FI89599B (fi) 1993-07-15
ATA236490A (de) 1994-05-15
SE9003704L (sv) 1991-05-23
NO177568C (no) 1995-10-11
ZA909026B (en) 1991-09-25
IE64402B1 (en) 1995-08-09
CA2029776A1 (fr) 1991-05-23
IE904207A1 (en) 1991-05-22
MA22001A1 (fr) 1991-07-01
CH681079A5 (fr) 1993-01-15
IT9022115A0 (it) 1990-11-20
NO905047L (no) 1991-05-23
SE505908C2 (sv) 1997-10-20
NZ235971A (en) 1993-02-25
FR2654622B1 (fr) 1995-01-13

Similar Documents

Publication Publication Date Title
ZA902871B (en) 3-substituted-2-oxindole derivatives
EP0430709A3 (en) Benzthiophen derivatives
EP0431421A3 (en) Heteroarylsubstituted pyridinylpyrimidin derivatives
GB2229723B (en) Thieno-triazolo-diazepine derivatives
GB2231330B (en) Thieno-triazolo-diazepine derivatives
ZA909798B (en) Pyridinylpyrimidine derivatives
ZA903984B (en) Phosphonomethylthioalkoxypyrine derivatives
IL94987A0 (en) Croman derivatives
GB2229724B (en) Thieno-triazolo-diazepine derivatives
EP0479951A4 (en) Bis-acyloxymethyl derivatives
ZA905456B (en) Dihydropyrimidothiazine derivatives
EP0411636A3 (en) Piperidylthiocarbapenem derivatives
GB8918275D0 (en) Fluoro-chloro-benzene derivatives
EP0438686A3 (en) Triazolylmethyl-cyclopropyl derivatives
GB2238310B (en) Selenophen derivatives
GB8916635D0 (en) Cardanolactam derivatives
GB9017950D0 (en) Fluoro-chloro-benzene derivatives
GB8913441D0 (en) Fluoro-chloro-benzene derivatives
IE893935L (en) Benzopyranylpyrrolinone derivatives
GB8913579D0 (en) Fluoro-chloro-benzene derivatives
ZA906023B (en) 1-phenylalkyl-3-phenylurea derivatives
ZA905417B (en) Thienodiazepine derivatives
GB8928445D0 (en) Benzofuranyl-imidazole derivatives
ZA90203B (en) Cyclohexaneacetamide derivatives
GB8913442D0 (en) Fluoro-chloro-benzene derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)